Impaired BDNF signaling through TrkB is associated with the pathophysiology of mood disorders and neuronal plasticity promoted by BDNF underlies some of the actions of antidepressant drugs (AD) (Duman and Monteggia, 2006; Castrén et al., 2007). The gene discussed is BDNF; the disease is Alzheimer disease.